We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Humana (HUM) Teams Up With DME Entities to Boost Home Solutions
Read MoreHide Full Article
Humana Inc. (HUM - Free Report) announced that it partnered with two national organizations to offer Durable Medical Equipment (DME) services, which will enable Humana Medicare Advantage HMO members to access services seamlessly at home. The organizations will offer DME services starting from Jul 1.
Through the partnership with Humana, AdaptHealth Corp. (AHCO - Free Report) and Rotech Healthcare Inc. are expected to serve specific regions in the domestic market under a value-based structure. The move is expected to enhance the capabilities of Humana’s Home Solutions business. The terms of the deals are yet to be disclosed.
The deals are expected to enable the company to scale its comprehensive value-based homecare offerings. By 2025, this will cover 40% of Humana Medicare Advantage members. The partnerships with AdaptHealth and Rotech Healthcare are expected to create a unified approach to sourcing durable medical equipment. This will not only help HMO members but also physicians and caregivers in their pursuit to provide quality and value-based care.
With the help of this unified approach, healthcare providers can speed up the ordering process and obtain medical equipment in a simplified manner. Partnerships like these are expected to equip HUM with the means to deploy advanced clinical programs that can reduce hospitalizations for the members. The partnerships with AdaptHealth and Rotech Healthcare will only be in effect for Humana Medicare Advantage HMO plans.
Humana’s Home Solutions operations are part of the CenterWell segment. In the first quarter of 2023, the company generated $314 million from Home Solutions in service revenues, which tumbled 56.7% year over year. However, its expansionary measures for the value-based care home model enabled the company to register 188.1% growth in Home Solutions intersegment revenues. The latest deals are expected to further boost these numbers in the coming days.
Price Performance
Humana’s shares have gained 23.3% in the past year compared with the 4.3% rise of the industry it belongs to.
The Zacks Consensus Estimate for Life Time Group’s 2023 earnings is pegged at 41 cents per share, indicating a massive improvement from the year-ago loss of 18 cents. The consensus estimate for LTH’s revenues in 2023 suggests a 22.8% year-over-year rise.
The consensus mark for Establishment Labs’ 2023 earnings has improved 6.2% in the past 30 days. The consensus estimate for ESTA’s revenues in 2023 suggests 27.6% year-over-year growth.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Humana (HUM) Teams Up With DME Entities to Boost Home Solutions
Humana Inc. (HUM - Free Report) announced that it partnered with two national organizations to offer Durable Medical Equipment (DME) services, which will enable Humana Medicare Advantage HMO members to access services seamlessly at home. The organizations will offer DME services starting from Jul 1.
Through the partnership with Humana, AdaptHealth Corp. (AHCO - Free Report) and Rotech Healthcare Inc. are expected to serve specific regions in the domestic market under a value-based structure. The move is expected to enhance the capabilities of Humana’s Home Solutions business. The terms of the deals are yet to be disclosed.
The deals are expected to enable the company to scale its comprehensive value-based homecare offerings. By 2025, this will cover 40% of Humana Medicare Advantage members. The partnerships with AdaptHealth and Rotech Healthcare are expected to create a unified approach to sourcing durable medical equipment. This will not only help HMO members but also physicians and caregivers in their pursuit to provide quality and value-based care.
With the help of this unified approach, healthcare providers can speed up the ordering process and obtain medical equipment in a simplified manner. Partnerships like these are expected to equip HUM with the means to deploy advanced clinical programs that can reduce hospitalizations for the members. The partnerships with AdaptHealth and Rotech Healthcare will only be in effect for Humana Medicare Advantage HMO plans.
Humana’s Home Solutions operations are part of the CenterWell segment. In the first quarter of 2023, the company generated $314 million from Home Solutions in service revenues, which tumbled 56.7% year over year. However, its expansionary measures for the value-based care home model enabled the company to register 188.1% growth in Home Solutions intersegment revenues. The latest deals are expected to further boost these numbers in the coming days.
Price Performance
Humana’s shares have gained 23.3% in the past year compared with the 4.3% rise of the industry it belongs to.
Image Source: Zacks Investment Research
Zacks Rank & Key Picks
Humana currently has a Zacks Rank #3 (Hold). Investors interested in the broader medical space may look at better-ranked players like Life Time Group Holdings, Inc. (LTH - Free Report) and Establishment Labs Holdings Inc. (ESTA - Free Report) , each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for Life Time Group’s 2023 earnings is pegged at 41 cents per share, indicating a massive improvement from the year-ago loss of 18 cents. The consensus estimate for LTH’s revenues in 2023 suggests a 22.8% year-over-year rise.
The consensus mark for Establishment Labs’ 2023 earnings has improved 6.2% in the past 30 days. The consensus estimate for ESTA’s revenues in 2023 suggests 27.6% year-over-year growth.